Replimune (REPL) Prepaid Assets (2018 - 2026)
Replimune (REPL) reported Prepaid Assets of $8.6 million for Q1 2026, up 3.11% on a YoY basis from $8.4 million in Q1 2025, and up 4.22% sequentially from $8.3 million in Q4 2025.
Replimune (REPL) Prepaid Assets (2018 - 2026) Analysis & Trends
Replimune (REPL) has 9 years of Prepaid Assets data on file, last reported at $8.6 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 3.11% year-over-year to $8.6 million; the trailing twelve-month figure through Mar 2026 stood at $8.6 million (up 3.11% YoY), and the FY2026 full-year result was $8.6 million, up 3.11% from the prior year.
- Prepaid Assets improved to $8.6 million in Q1 2026, from $8.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $8.6 million in Q1 2026 to a low of $4.0 million in Q2 2022.
- A 5-year average of $7.3 million and a median of $8.1 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets surged 95.42% in 2023 and retreated 20.67% in 2024, its largest moves.
- Tracing REPL's Prepaid Assets over 5 years: stood at $5.6 million in 2022, then surged by 52.35% to $8.5 million in 2023, then declined by 6.41% to $8.0 million in 2024, then increased by 3.64% to $8.3 million in 2025, then climbed by 4.22% to $8.6 million in 2026.
- Business Quant data shows REPL's Prepaid Assets at $8.6 million in Q1 2026, $8.3 million in Q4 2025, and $8.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.61 Mn |
| Dec 31, 2025 | 8.26 Mn |
| Sep 30, 2025 | 8.30 Mn |
| Jun 30, 2025 | 8.19 Mn |
| Mar 31, 2025 | 8.35 Mn |
| Dec 31, 2024 | 7.97 Mn |
| Sep 30, 2024 | 8.53 Mn |
| Jun 30, 2024 | 6.26 Mn |
| Mar 31, 2024 | 8.08 Mn |
| Dec 31, 2023 | 8.52 Mn |
| Sep 30, 2023 | 8.51 Mn |
| Jun 30, 2023 | 7.90 Mn |
| Mar 31, 2023 | 6.28 Mn |
| Dec 31, 2022 | 5.59 Mn |
| Sep 30, 2022 | 4.98 Mn |
| Jun 30, 2022 | 4.04 Mn |
| Mar 31, 2022 | 5.27 Mn |
| Dec 31, 2021 | 5.41 Mn |
| Sep 30, 2021 | 5.73 Mn |
| Jun 30, 2021 | 3.26 Mn |